Publications by authors named "Evangelia Iliaki"
The mRNA-based BNT162b2 vaccine has demonstrated high efficacy against severe SARS-CoV-2. However, data regarding immune response in people with diabetes mellitus (DM) after vaccination with the BNT162b2 vaccine are limited. In this prospective observational study, we examined humoral immune response in participants with and without DM after vaccination with the BNT162b2 mRNA vaccine.
View Article and Find Full Text PDFArticle Synopsis
- A study conducted on healthcare professionals aimed to evaluate the immune response and side effects from the BNT162b2 COVID-19 mRNA vaccine, measuring immunoglobulin G (IgG) levels after full vaccination.
- The results showed that females, non-smokers, and younger individuals had higher IgG titers, while common side effects included pain at the injection site, fatigue, and malaise.
- The findings emphasize the importance of ongoing monitoring of vaccine-induced immunity and identifying individuals at higher risk for lower antibody responses.